The partners at the centre of Blis patent dispute named

The partners at the centre of Blis patent dispute named
The Swiss-registered Spanish company signed an exclusive deal with Blis in 2015. (Image: NZME)
Denise McNabb
Two executives from Blis Technologies’ long-time European partner, Bluestone Pharma, are named on a patent application as inventors of two fermentation processes Blis claims as its own technology.The executives are Michael Faber, Swiss-registered Bluestone Pharma’s managing partner, and Karsten Brandt, its chief scientific officer. The Swiss-registered Spanish company signed an exclusive deal with Blis in 2015 to distribute its healthcare products in Europe. At the time, Blis said the relationship with Bluestone Pharma (BP) hel...

More Markets

NZ stocks end lower while Eroad tanks
Markets Market Close

NZ stocks end lower while Eroad tanks

The S&P/NZX 50 Index dropped 99.89 points or 0.75% to 13,289.21.

Jamie Gray 17 Oct 2025
Macpac NZ profits drop 71% as softer sales hit margins
Retail

Macpac NZ profits drop 71% as softer sales hit margins

The sales drop in New Zealand was larger than Kathmandu's.

Gregor Thompson 17 Oct 2025
Eroad shares slump 23% as it shifts focus from North America
Markets

Eroad shares slump 23% as it shifts focus from North America

Eroad cuts North America exposure, impairing $150m in assets.

Rebecca Howard 17 Oct 2025
$55m deal secures Santana mining land
Primary Sector

$55m deal secures Santana mining land

The gold miner now owns all the land where its best mining prospects lie.  

Pattrick Smellie 17 Oct 2025